New Technology for Lung and Airway Disease

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Douglas Minnich, MD
Luis Herrera, MD

Disclosure: Intuitive Surgical, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Presentations

  1. Non-Small Cell Lung Cancer Precision Cut Lung Slices as a Translational Model for Prospective Validation of Molecular Imaging Fluorophores
    Feredun Azari, MD
     
  2. Novel Composite Hydrogels for Tissue Engineered Tracheal Grafts
    Russell Seth Martins, MBBS
     
  3. 3D Deep Learning in Predicting Tumor Invasiveness of Lung Adenocarcinoma
    Yilv Lv, MD
     
  4. Endoscopic Treatment of Lung Cancer
    Calvin S.H Ng, MD FRCS FCCP
    Disclosure: Astra Zeneca: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Galvanize Therapeutics Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson and Johnson: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
     
  5. The World Needs More Unicorns: Where IP and TS Align
    Biniam Kidane, MD, MSc, FRCSC
    Disclosure: Medtronic, Edwards, Boston Scientific, Abbott: Advisory Board (Terminated, August 26, 2022); AstraZeneca Pharmaceuticals: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Activity opens: 
02/01/2023
Activity expires: 
02/01/2026
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Douglas Minnich, MD
Luis Herrera, MD

Disclosure: Intuitive Surgical, Inc.: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Presentations

  1. Non-Small Cell Lung Cancer Precision Cut Lung Slices as a Translational Model for Prospective Validation of Molecular Imaging Fluorophores
    Feredun Azari, MD
     
  2. Novel Composite Hydrogels for Tissue Engineered Tracheal Grafts
    Russell Seth Martins, MBBS
     
  3. 3D Deep Learning in Predicting Tumor Invasiveness of Lung Adenocarcinoma
    Yilv Lv, MD
     
  4. Endoscopic Treatment of Lung Cancer
    Calvin S.H Ng, MD FRCS FCCP
    Disclosure: Astra Zeneca: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Galvanize Therapeutics Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson and Johnson: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
     
  5. The World Needs More Unicorns: Where IP and TS Align
    Biniam Kidane, MD, MSc, FRCSC
    Disclosure: Medtronic, Edwards, Boston Scientific, Abbott: Advisory Board (Terminated, August 26, 2022); AstraZeneca Pharmaceuticals: Advisory Board (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck: Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)